Daejeon, South Korea

Jung a Kim

This inventor holds 1 USPTO granted patent. Top assignee: Lg Chem, Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jung a Kim. Retrieved from https://idiyas.com/inventor/jung-a-kim-wkdef987

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jung a Kim

Introduction

Jung a Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing science.

Latest Patents

Jung a Kim holds a patent for an "ANTI-LILRB1 ANTIBODY AND USES THEREOF." This patent represents a crucial advancement in therapeutic options, potentially aiding in the treatment of various diseases. With 1 patent to his name, his contributions are already making an impact in the industry.

Career Highlights

Currently, Jung a Kim is employed at LG Chem, Ltd., a leading chemical company in South Korea. His role at LG Chem allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His work is instrumental in pushing the boundaries of what is possible in biotechnology.

Collaborations

Jung a Kim has worked alongside talented colleagues, including Saem Jung and Ji Hyun Lee. These collaborations enhance the innovative potential of their projects and foster a creative environment for scientific discovery.

Conclusion

Jung a Kim exemplifies the spirit of innovation in biotechnology through his patent and work at LG Chem, Ltd. His contributions are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…